A Phase 2a, Multi Site, Randomized, Double Blind, Placebo Controlled, Parallel Group Study Of The Pilot Efficacy, Safety, And Pharmacokinetics Of 2 Ointment Formulations Of CP-690,550 In Subjects With Mild To Moderate Chronic Plaque Psoriasis.

Trial Profile

A Phase 2a, Multi Site, Randomized, Double Blind, Placebo Controlled, Parallel Group Study Of The Pilot Efficacy, Safety, And Pharmacokinetics Of 2 Ointment Formulations Of CP-690,550 In Subjects With Mild To Moderate Chronic Plaque Psoriasis.

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Mar 2013

At a glance

  • Drugs Tofacitinib (Primary)
  • Indications Plaque psoriasis
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 05 Mar 2013 Pruritis and patient satisfaction results presented at the 71st Annual Meeting of the American Academy of Dermatology.
    • 05 Mar 2013 Primary endpoint 'Target-Plaque-Severity-Score' has been met for formulation one versus vehicle one as presented at the 71st Annual Meeting of the American Academy of Dermatology.
    • 05 Mar 2013 Results presented at the 71st Annual Meeting of the American Academy of Dermatology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top